Medical Devices: Page 69
-
Retrieved from LinkedIn on January 04, 2023
ReCor names Healthineers exec Barghout as CEO ahead of showdown with Medtronic
ReCor is preparing to go up against Medtronic with its renal denervation system, in a market that the latter expects to grow to $3 billion by the end of the decade.
By Nick Paul Taylor • Jan. 4, 2023 -
Courtesy of AliveCor
Apple infringed on AliveCor wearable patents, ITC says in final ruling; import ban suspended
The commission found that Apple has infringed on two AliveCor patents and thereby violated a law that can trigger an import ban.
By Nick Paul Taylor • Jan. 4, 2023 -
Explore the Trendline➔
Sara Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From haphazard layoffs at the Food and Drug Administration to the industry’s current IPO environment and tracking FDA-authorized AI devices, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
ryasick via Getty Images
Deep DiveA look back at medtech’s top 10 acquisitions of 2022
While larger acquisitions were announced at the end of the year including J&J’s $16.6B purchase of Abiomed, the number of deals declined from 2021.
By Elise Reuter • Dec. 22, 2022 -
Mario Tama via Getty Images
J&J closes acquisition of heart pump maker Abiomed
The $16.6 billion purchase was the largest medtech transaction of 2022.
By Elise Reuter • Dec. 22, 2022 -
Courtesy of Philips
Philips’ studies argue recalled DreamStation CPAP machines unlikely to harm patients’ health
In a briefing on testing of the machines, Philips said exposure to degraded foam used to soundproof the devices is unlikely to harm patients.
By Elise Reuter • Dec. 21, 2022 -
Brendan Hoffman via Getty Images
Diagnostic testing reform missing from Congress’ year-end spending bill
A provision that would have brought in-vitro diagnostic tests and lab-developed tests under one regulatory framework was not included in the omnibus spending bill.
By Elise Reuter • Dec. 21, 2022 -
Courtesy of Odin Vision
Olympus agrees to $80M takeover of artificial intelligence endoscopy startup Odin Vision
The acquisition gives Olympus control of cloud-based AI systems to help detect and characterize cancerous and precancerous tissues during colonoscopies and gastroscopies.
By Nick Paul Taylor • Dec. 21, 2022 -
Pixelseffect via Getty Images
As diabetes technology advances, blood glucose control declines: study
Mexican-American and non-Hispanic Black adults saw the greatest drop as the proportion of patients with glycemic control fell from 29.2% between 1988 and 1994 to 27.5% between 2013 and 2020.
By Nick Paul Taylor • Dec. 21, 2022 -
Courtesy of Medtronic
Medtronic starts US robotic surgery trial in push to challenge Intuitive
Medtronic delayed the Hugo program to make changes in light of surgeon feedback, but now plans to evaluate the use of the surgical robot in urologic procedures, facing off against competitor Intuitive.
By Nick Paul Taylor • Dec. 20, 2022 -
titoOnz via Getty Images
MDR costs are driving manufacturers to pull products from European market: report
The report adds to evidence that makers of products used for pediatric patients and rare diseases have been particularly hard hit.
By Nick Paul Taylor • Dec. 20, 2022 -
Popovaphoto via Getty Images
Fraud risk increased among Medicare DME suppliers who enrolled under pandemic waivers: GAO
Of 208 providers that had their Medicare enrollment revoked between 2020 and 2022, 83% were durable medical equipment suppliers, according to a report from the Government Accountability Office.
By Elise Reuter • Dec. 19, 2022 -
J&J subsidiaries accuse former Auris employees of stealing robotic surgery trade secrets
The lawsuit claims former Auris employees engaged in “shameless, systematic and ongoing misappropriation of trade secrets.”
By Nick Paul Taylor • Dec. 19, 2022 -
Prostock-Studio via Getty Images
Click wins FDA breakthrough designation for prescription digital migraine therapy
The designation would give Click Therapeutics expedited review of its preventive treatment for episodic migraine in adults.
By Nick Paul Taylor • Dec. 19, 2022 -
Courtesy of Synchron
Gates, Bezos invest in Synchron’s brain computer interface
A $75 million investment will accelerate the development of a drill-free implant to help patients with upper-limb paralysis.
By Peter Green • Dec. 16, 2022 -
Siemens, GE Healthcare are interested in Medtronic spinoff units: Bloomberg
Medtronic said in October it plans to divest its patient monitoring and respiratory interventions businesses.
By Elise Reuter • Dec. 15, 2022 -
Courtesy of Masimo
Masimo links passive health monitors to home stereos amid legal row with Apple
The move integrates the consumer audio brands Masimo bought in April with its wearable health monitors.
By Peter Green • Dec. 15, 2022 -
Courtesy of Dexcom
Dexcom’s Jake Leach discusses preparations for G7 launch next year
The diabetes tech company is in conversations with payers and is opening a new manufacturing plant ahead of the planned launch of its newest CGM, the COO said.
By Elise Reuter • Dec. 15, 2022 -
Courtesy of HistoSonics
J&J leads $85M investment in HistoSonics ahead of liver cancer device authorization
HistoSonics is developing a device that delivers focused ultrasound to destroy and liquefy unwanted tissue and tumors without the need for surgical incisions.
By Nick Paul Taylor • Dec. 14, 2022 -
Courtesy of Tandem Diabetes
Tandem agrees to buy AMF, challenging Insulet for insulin pump patch market
The deal will give Tandem control of Sigi, a reusable, rechargeable patch pump that is designed to be smaller and lighter than existing devices.
By Nick Paul Taylor • Dec. 14, 2022 -
Courtesy of Masimo
Deep DiveApple locked in court battles with small medtech firms over allegations of stolen technology
AliveCor and Masimo are looking to bar Apple from selling watches that use technology the firms claim they invented.
By Elise Reuter , Nick Paul Taylor • Updated Dec. 13, 2022 -
Courtesy of Boston Scientific
Boston Scientific pays $523M for control of Chinese device maker Acotec
The acquisition will give Boston greater access to the Chinese market, which the U.S. firm expects will account for 25% of the global medtech demand by 2030.
By Peter Green • Dec. 12, 2022 -
Courtesy of Ypsomed
Ypsomed seeks new partner for US insulin pump launch as Lilly quits deal
The companies planned to launch a customized version of the YpsoPump that used pre-filled insulin cartridges for Lilly’s rapid-acting insulins.
By Nick Paul Taylor • Dec. 12, 2022 -
artJazz via Getty Images
EU Health Commissioner proposes MDR delay to prevent medical device shortages
Plans to delay MDR certification to 2027 for high-risk devices and 2028 for others may still not be enough to stave off shortages.
By Nick Paul Taylor • Updated Dec. 23, 2022 -
Courtesy of Vaxxas
Investors hand Vaxxas $23M to support trial of needle-free COVID-19 vaccine
With support from the Gates Foundation, the needle-free technology could get more people vaccinated and avoid cold-chain issues.
By Nick Paul Taylor • Dec. 12, 2022 -
Peter S Green/MedTech Dive
Q&AFriday Q&A: GE Healthcare’s Arduini, Zodl talk about spinoff, M&A, margins, Jack Welch
The CEO and CFO of the company spoke with MedTech Dive just weeks before the healthcare business formally separates from General Electric.
By Peter Green • Dec. 9, 2022
Previous
